AliveDx Submits 510(k) Application for MosaiQ AiPlex CTDplus Microarray to FDA AliveDx has filed a 510(k) application for the innovative MosaiQ AiPlex CTDplus microarray, targeting advancements in connective tissue disease diagnostics.

AliveDx Submits 510(k) Application for MosaiQ AiPlex CTDplus Microarray to FDA #USA #AliveDx #Eysins #MosaiQ_AiPlex #CTDplus